Literature DB >> 29477572

Multiple regulatory actions of 2-guanidine-4-methylquinazoline (GMQ), an agonist of acid-sensing ion channel type 3, on ionic currents in pituitary GH3 cells and in olfactory sensory (Rolf B1.T) neurons.

Edmund Cheung So1, Yingwei Wang2, Li Qun Yang3, Kenny Hsu So4, Yi-Ching Lo5, Sheng-Nan Wu6.   

Abstract

GMQ (2-guanidine-4-methylquinazoline or N-(4-methyl-2-quinazolinyl)-guanidine hydrochloride), an agonist of acid-sensing ion channel type 3, has been increasingly used for in vivo studies of alternations in nociceptic behavior. In this study, we tried to investigate whether GMQ has any possible effect on other types of ion channels. Addition of GMQ to pituitary GH3 cells raised the amplitude of Ca2+-activated K+ currents (IK(Ca)), which was reversed by verruculogen or PF1022A, but not by TRAM-39. Under inside-out current recordings, addition of GMQ into bath enhanced the probability of large-conductance Ca2+-activated K+ (BKCa) channels with an EC50 value of 0.95 µM. The activation curve of BKCa channels during exposure to GMQ shifted to a lower depolarized potential, with no change in the gating charge of the curve; however, there was a reduction of free energy for channel activation in its presence. As cells were exposed to GMQ, the amplitude of ion currents were suppressed, including delayed rectifying K+ current, voltage-gated Na+ and L-type Ca2+ currents. In Rolf B1.T olfactory sensory neuron, addition of GMQ was able to induce inward current and to suppress peak INa. Taken together, findings from these results indicated that in addition to the activation of ASIC3 channels, this compound might directly produce additional actions on various types of ion channels. Caution should be taken in the interpretation of in vivo experimental results when GMQ or other structurally similar compounds are used as targets to characterize the potential functions of ASIC3 channels.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ca(2+)-activated K(+) current; L-type Ca(2+) current; Large-conductance Ca(2+)-activated K(+) channel; Na(+) current; Olfactory sensory neuron; Pituitary cell

Mesh:

Substances:

Year:  2018        PMID: 29477572     DOI: 10.1016/j.bcp.2018.02.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Bisoprolol, Known to Be a Selective β₁-Receptor Antagonist, Differentially but Directly Suppresses IK(M) and IK(erg) in Pituitary Cells and Hippocampal Neurons.

Authors:  Edmund Cheung So; Ning-Ping Foo; Shun Yao Ko; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

2.  Endogenous Neuropeptide Nocistatin Is a Direct Agonist of Acid-Sensing Ion Channels (ASIC1, ASIC2 and ASIC3).

Authors:  Dmitry I Osmakov; Sergey G Koshelev; Igor A Ivanov; Yaroslav A Andreev; Sergey A Kozlov
Journal:  Biomolecules       Date:  2019-08-22

3.  Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents.

Authors:  Wei-Ting Chang; Zi-Han Gao; Shih-Wei Li; Ping-Yen Liu; Yi-Ching Lo; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2020-01-08       Impact factor: 5.923

4.  High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih.

Authors:  Te-Ling Lu; Zi-Han Gao; Shih-Wei Li; Sheng-Nan Wu
Journal:  Biomolecules       Date:  2020-01-25

5.  Effectiveness in the Block by Honokiol, a Dimerized Allylphenol from Magnolia Officinalis, of Hyperpolarization-Activated Cation Current and Delayed-Rectifier K+ Current.

Authors:  Ming-Huan Chan; Hwei-Hsien Chen; Yi-Ching Lo; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

6.  Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents.

Authors:  Mei-Han Huang; Ping-Yen Liu; Sheng-Nan Wu
Journal:  Front Chem       Date:  2019-08-22       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.